| Inventor | Institute |
|---|---|
| Bernhard Singer | Leukocom GmbH |
| Product description: | Anti-CEACAM1/3/5 [SAB135] is a mouse IgG1/kappa monoclonal antibody that recognises the N-terminal region of human CEACAM1 (CD66a), CEACAM3 (CD66d) and CEACAM5 (CEA/CD66e), with highest affinity for CEACAM5. It showed no detectable binding to the other CEACAM family members tested or to murine CEACAM1. CEACAMs are cell adhesion molecules. CEACAM5 is expressed in normal intestinal epithelium and can be overexpressed in breast, lung, colorectal and gastrointestinal carcinomas. |
|---|---|
| Alternate name: | Anti human CEACAM1/3/5 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Molecular weight: | CEACAM1: variable. CEACAM3: 27 kDa. CEA: 77 kDa, apparent 180 kDa comprising 80% carbohydrate. |
| Immunogen: | Recombinant CEACAM5-huFc produced in HEK293 transfectants. |
| Cat. #: | 162449 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Immunology |
| Application: | Flow Cytometry, ELISA, IHC, IP, WB |
| Target: | Binds to human CEACAM1,3,5. |
| Reactivity: | Human |
| Clone: | SAB135 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Khairnar et al. 2015. Nat Commun. 6:6217. PMID: 25692415. |
| Target background: | SAB135 binds to the N-terminal region of the CEACAM1,3 and 5 (5). |
|---|
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Han et al. 2020. Invest New Drugs. 38(6):1888-1898. PMID: 32488569 Khairnar et al. 2018. Nat Commun. 9(1):2561. PMID: 29967450. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.